Naturhouse Health, S.A. (BME:NTH)

Spain · Delayed Price · Currency is EUR

2.520

-0.030 (-1.18%)

Aug 7, 2026, 10:21 AM CET

Naturhouse Health Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.43	20.68	24.39	12.11	27.25
Cash & Short-Term Investments	13.43	20.68	24.39	12.11	27.25
Cash Growth	-35.09%	-15.19%	101.41%	-55.57%	26.09%
Accounts Receivable	1.45	1.96	2.51	2.4	2.71
Other Receivables	0.49	0.7	1.54	6.76	3.99
Total Trade Receivables	1.94	2.67	4.06	9.16	6.7
Inventory	2.92	3.45	2.75	2.67	2.55
Other Current Assets	1.31	1.38	3.17	3.13	0.78
Total Current Assets	19.59	28.18	34.37	27.07	37.28
Net Property, Plant & Equipment	2.59	3.33	3.67	-	-
Other Intangible Assets	0.37	-	-	3.98	2.67
Goodwill	-	0.37	0.44	0.61	0.75
Long-Term Investments	10.81	10.2	9.82	10.55	6.79
Other Long-Term Assets	0.07	0.06	0.08	0.08	0.11
Total Assets	33.43	42.59	48.85	42.82	49

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.29	2.67	2.72	1.9	2.01
Accrued Expenses	2.48	2.4	5.06	4.57	4.08
Short-Term Debt	0.49	1	4.52	1.52	0.99
Other Current Liabilities	0.54	0.39	0.47	0.4	0.98
Total Current Liabilities	11.88	6.46	12.76	8.39	8.06
Long-Term Leases	2.86	3.27	3.54	3.86	3.38
Other Long-Term Liabilities	0.94	1.17	1.92	2.71	1.48
Total Long-Term Liabilities	3.8	4.44	5.45	6.56	4.86
Total Liabilities	15.68	10.91	18.21	14.96	12.92

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	3	3	6	6	3
Treasury Stock	-0.14	-0.14	-0.14	-0.14	-0.14
Additional Paid-in Capital	2.15	2.15	2.15	2.15	2.15
Accumulated Other Comprehensive Income	-0.3	-0.28	-0.71	-2.26	-2.37
Retained Earnings	13.05	26.96	25.86	23.61	31.86
Total Common Shareholders' Equity	17.75	31.69	30.63	27.86	36.08
Shareholders' Equity	17.76	31.69	30.63	27.86	36.08
Total Liabilities & Equity	33.43	42.59	48.85	42.82	49

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	3.35	4.27	8.05	5.38	4.37
Net Cash (Debt)	10.07	16.41	16.33	6.73	22.88
Net Cash Growth	-38.62%	0.47%	142.85%	-70.61%	5.89%
Net Cash Per Share	0.17	0.27	0.27	0.11	0.38
Book Value	17.75	31.69	30.63	27.86	36.08
Book Value Per Share	0.30	0.53	0.51	0.46	0.60
Tangible Book Value	17.38	31.32	30.19	23.27	32.65
Tangible Book Value Per Share	0.29	0.52	0.50	0.39	0.54